The Comprehensive Guide to Dacarbazine 500mg Injection In the specialized field of oncology, Dacarbazine 500mg Injection (also known as DTIC) remains a critical chemotherapy agent for treating aggressive malignancies. As a premier pharmaceutical exporter from India, Ernest Oncology (a group of Ernest Pharmaceutical Pvt. Ltd.) ensures that this vital medication is available to healthcare providers and hospitals in London, New York, Sydney, Johannesburg, and beyond. Product Specifications Brand Name: Ernest-Oncology (Dacarbazine) Strength: 500 mg per vial Dosage Form: Lyophilized Powder for Injection (Intravenous) Primary Indication: Metastatic malignant melanoma and Hodgkin’s Lymphoma. Storage: Store unopened vials in a refrigerator (2°C to 8°C / 36°F to 46°F) and protect from light. Mechanism of Action: How It Works DNA Methylation: Once activated by liver enzymes, it acts as a purine analog, interfering with DNA synthesis by causing methylation and cross-linking of DNA strands. Halting Cell Division: By damaging the genetic material (DNA and RNA) of cancer cells, it effectively stops their ability to grow, multiply, and spread throughout the body. Therapeutic Indications & Administration Malignant Melanoma: Used as a first-line treatment for metastatic melanoma that has spread to other parts of the body. Hodgkin’s Lymphoma: Typically used as a secondary therapy or as part of the standard ABVD (Adriamycin, Bleomycin, Vinblastine, Dacarbazine) regimen. Administration: * Intravenous Route: Must be administered as an IV infusion by a qualified oncology professional. Vesicant Warning: It is a potent irritant; careful administration is required to avoid extravasation (leaking into surrounding tissues), which can cause severe local pain and tissue damage. Dietary Note: Restriction of food intake for 4–6 hours prior to therapy can help prevent severe gastrointestinal side effects Clinical Side Effects & Safety Gastrointestinal Effects: Severe nausea and vomiting are very common (>90% of patients), often requiring prophylactic antiemetic treatment. Myelosuppression: The most common serious toxicity, causing a decrease in blood cell counts (white cells, red cells, and platelets), which increases the risk of infection and bleeding. Hepatotoxicity: Rare but serious liver damage or hepatic necrosis has been reported; liver function tests are monitored regularly. Flu-like Syndrome: Patients may experience fever, muscle aches, and malaise, typically occurring 7 days after treatment begins. Photosensitivity: Increased sensitivity to sunlight; patients should use protective measures when outdoors. Why Source from Ernest Oncology? United Kingdom (London): Supplying cost-effective oncology solutions for specialized clinics and hospitals. USA: Delivering bulk quantities that meet international safety and documentation standards. Australia: Ensuring stable access through established “Special Access Scheme“ (SAS) supply chains. South Africa: Bridging critical gaps in the oncology market with reliable, high-tier pharmaceutical exports from India. 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 📦 Business Type: Exporter | Bulk Supplier | Distributor 🌐 Websites: www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com www.ernestvision.com www.ernestimpex.com 📧 Email: exports@ernestpharmaceuticals.com 📲 WhatsApp: +91 3599 02383 🔗 Direct Link: https://wa.me/919359902383
Washington, USA
08048034998
+919405476170
Chat with us
Chat with us